Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275(5308):1943–7. https://doi.org/10.1126/science.275.5308.1943. (PMID: 9072974).

Article  CAS  PubMed  Google Scholar 

Eng C. PTEN: one gene, many syndromes. Hum Mutat. 2003;22(3):183–98. https://doi.org/10.1002/humu.10257. (PMID: 12938083).

Article  CAS  PubMed  Google Scholar 

Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997;15(4):356–62. https://doi.org/10.1038/ng0497-356. (PMID: 9090379).

Article  CAS  PubMed  Google Scholar 

Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA. 1998;95(23):13513–8. https://doi.org/10.1073/pnas.95.23.13513.PMID:9811831;PMCID:PMC24850.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998;95(1):29–39. https://doi.org/10.1016/s0092-8674(00)81780-8. (PMID: 9778245).

Article  CAS  PubMed  Google Scholar 

Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell. 2007;128(1):157–70. https://doi.org/10.1016/j.cell.2006.11.042. (PMID: 17218262).

Article  CAS  PubMed  Google Scholar 

Bassi C, Ho J, Srikumar T, Dowling RJ, Gorrini C, Miller SJ, Mak TW, Neel BG, Raught B, Stambolic V. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science. 2013;341(6144):395–9. https://doi.org/10.1126/science.1236188.Erratum.In:Science.2013Sep6;341(6150):1064.PMID:23888040;PMCID:PMC5087104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou SQ, Ouyang M, Brandmaier A, Hao H, Shen WH. PTEN in the maintenance of genome integrity: From DNA replication to chromosome segregation. BioEssays. 2017;39(10):1700082. https://doi.org/10.1002/bies.201700082.

Article  CAS  Google Scholar 

Brandmaier A, Hou SQ, Shen WH. Cell cycle control by PTEN. J Mol Biol. 2017;429(15):2265–77. https://doi.org/10.1016/j.jmb.2017.06.004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mansour WY, Tennstedt P, Volquardsen J, Oing C, Kluth M, Hube-Magg C, Borgmann K, Simon R, Petersen C, Dikomey E, Rothkamm K. Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer. Sci Rep. 2018;8(1):3947. https://doi.org/10.1038/s41598-018-22289-7.PMID:29500400;PMCID:PMC5834544.

Article  CAS  PubMed  PubMed Central  Google Scholar 

He J, Kang X, Yin Y, Chao KS, Shen WH. PTEN regulates DNA replication progression and stalled fork recovery. Nat Commun. 2015;9(6):7620. https://doi.org/10.1038/ncomms8620.PMID:26158445;PMCID:PMC4499867.

Article  Google Scholar 

Sun Z, Lu J, Wu M, Li M, Bai L, Shi Z, Hao L, Wu Y. Deficiency of PTEN leads to aberrant chromosome segregation through downregulation of MAD2. Mol Med Rep. 2019;20(5):4235–43. https://doi.org/10.3892/mmr.2019.10668.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuen KW, Montpetit B, Hieter P. The kinetochore and cancer: what’s the connection? Curr Opin Cell Biol. 2005;17(6):576–82. https://doi.org/10.1016/j.ceb.2005.09.012. (Epub 2005 Oct 17 PMID: 16233975).

Article  CAS  PubMed  Google Scholar 

Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L, Mansukhani M, Murty VV, Gaciong Z, Meek SE, Piwnica-Worms H, Hibshoosh H, Parsons R. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell. 2005;7(2):193–204. https://doi.org/10.1016/j.ccr.2005.01.009. (PMID: 15710331).

Article  CAS  PubMed  Google Scholar 

Sun Z, Huang C, He J, Lamb KL, Kang X, Gu T, Shen WH, Yin Y. PTEN C-terminal deletion causes genomic instability and tumor development. Cell Rep. 2014;6(5):844–54. https://doi.org/10.1016/j.celrep.2014.01.030.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem. 2001;276(52):48627–30. https://doi.org/10.1074/jbc.C100556200. (Epub 2001 Nov 13 PMID: 11707428).

Article  CAS  PubMed  Google Scholar 

Lang V, Aillet F, Da Silva-Ferrada E, Xolalpa W, Zabaleta L, Rivas C, Rodriguez MS. Analysis of PTEN ubiquitylation and SUMOylation using molecular traps. Methods. 2015;77–78:112–8. https://doi.org/10.1016/j.ymeth.2014.09.001. (Epub 2014 Sep 16 PMID: 25224693).

Article  CAS  PubMed  Google Scholar 

Meng Z, Jia LF, Gan YH. PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition. Oncogene. 2016;35(18):2333–44. https://doi.org/10.1038/onc.2015.293. (Epub 2015 Aug 17 PMID: 26279303).

Article  CAS  PubMed  Google Scholar 

Zhang Y, Park J, Han SJ, Yang SY, Yoon HJ, Park I, Woo HA, Lee SR. Redox regulation of tumor suppressor PTEN in cell signaling. Redox Biol. 2020;34:101553. https://doi.org/10.1016/j.redox.2020.101553.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi BH, Pagano M, Dai W. Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle. J Biol Chem. 2014;289(20):14066–74. https://doi.org/10.1074/jbc.M114.558155.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Al-Khouri AM, Ma Y, Togo SH, Williams S, Mustelin T. Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta. J Biol Chem. 2005;280(42):35195–202. https://doi.org/10.1074/jbc.M503045200. (Epub 2005 Aug 17 PMID: 16107342).

Article  CAS  PubMed  Google Scholar 

Vazquez F, Ramaswamy S, Nakamura N, Sellers WR. Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol. 2000;20(14):5010–8. https://doi.org/10.1128/mcb.20.14.5010-5018.2000.PMID:10866658;PMCID:PMC85951.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torres J, Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus: implications for PTEN stability to proteasome-mediated degradation. J Biol Chem. 2001;276(2):993–8. https://doi.org/10.1074/jbc.M009134200. (PMID: 11035045).

Article  CAS  PubMed  Google Scholar 

Ginn-Pease ME, Eng C. Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0–G1 in MCF-7 cells. Cancer Res. 2003;63(2):282–6 (PMID: 12543774).

CAS  PubMed  Google Scholar 

Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X, Wu H. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA. 1999;96(11):6199–204. https://doi.org/10.1073/pnas.96.11.6199.PMID:10339565;PMCID:PMC26859.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, Gahman TC, Shiau AK, Zhou H, DeGroot J, Sulman EP, Cavenee WK, Kolodner RD, Chen CC, Furnari FB. Inhibition of nuclear PTEN tyrosine phosphorylation enhances glioma radiation sensitivity through attenuated DNA repair. Cancer Cell. 2019;35(3):504–18.e7. doi: https://doi.org/10.1016/j.ccell.2019.01.020. Epub 2019 Feb 28. Erratum in: Cancer Cell. 2019 May 13;35(5):816. Erratum in: Cancer Cell. 2019 Dec 9;36(6):690–91. PMID: 30827889; PMCID: PMC6424615.

Misra S, Chowdhury SG, Ghosh G, Mukherjee A, Karmakar P. Both phosphorylation and phosphatase activity of PTEN are required to prevent replication fork progression during stress by inducing heterochromatin. Mutation Res/Fundamental Mol Mech Mutagen. 2022;825:111800. https://doi.org/10.1016/j.mrfmmm.2022.111800.

Article  CAS  Google Scholar 

Barr FA, Silljé HH, Nigg EA. Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol. 2004;5(6):429–40. https://doi.org/10.1038/nrm1401. (PMID: 15173822).

Article  CAS  PubMed  Google Scholar 

Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov. 2010;9(8):643–60. https://doi.org/10.1038/nrd3184. (PMID: 20671765).

Article  CAS  PubMed  Google Scholar 

Liu X, Erikson RL. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA. 2003;100(10):5789–94. https://doi.org/10.1073/pnas.1031523100.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smits VA, Klompmaker R, Arnaud L, Rijksen G, Nigg EA, Medema RH. Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol. 2000;2(9):672–6. https://doi.org/10.1038/35023629. (PMID: 10980711).

Article  CAS  PubMed  Google Scholar 

Liu XS, Li H, Song B, Liu X. Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery. EMBO Rep. 2010;11(8):626–32. https://doi.org/10.1038/embor.2010.90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bassermann F, Frescas D, Guardavaccaro D, Busino L, Peschiaroli A, Pagano M. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell. 2008;134(2):256–67. https:/